Sec. 203. Authorization for United States participation in the Coalition for Epidemic Preparedness Innovations
192 words·~1 min read·
/bill/116/s/3669/is/section-203A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
The United States shall participate in the Coalition for Epidemic Preparedness Innovations. Not later than 180 days after the date of the enactment of this Act, the President shall submit to the appropriate congressional committees a report that describes the following: The United States planned contributions to the Coalition for Epidemic Preparedness Innovations (in this section referred to as the Coalition ) and the mechanisms for United States participation in the Coalition.
The manner and extent to which the United States shall participate in the governance of the Coalition. The role of the Coalition in and anticipated benefits of United States participation in the Coalition on— the Global Health Security Strategy required by section 7058(c)(3) of the Department of State, Foreign Operations, and Related Programs Appropriations Act, 2018 (division K of Public Law 115–141 ); the applicable revision of the National Biodefense Strategy required by section 1086 of the National Defense Authorization Act for Fiscal Year 2017 ( 6 U.S.C. 104 ); and any other relevant policy and planning process.
There is authorized to be appropriated $200,000,000 to carry out global health security, for contributions to the Coalition for Epidemic Preparedness Innovations.
Connectionstraces to 2
Traces to 2 documents
public-private-law
U.S. Code
Citation graph
cites case law
Sec. 203
Authorization for United States participation in the Coalition for Epidemic Preparedness Innovations
Cites 2Cited by 0 across 0 sources